Company Filing History:
Years Active: 2025
Title: Huijun Nie: Innovator in Antitumor Drug Development
Introduction
Huijun Nie is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for cancer treatment. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Huijun Nie holds a patent for an isoindoline compound, which includes a preparation method, pharmaceutical composition, and its uses. The invention relates to a polysubstituted isoindoline compound, which is a class of novel CRL4E3 ubiquitin ligase modulators. This compound exhibits stronger antitumor activity and a broader antitumor spectrum, making it a promising candidate for drug development aimed at treating CRL4E3 ligase-related diseases. He has 1 patent to his name.
Career Highlights
Huijun Nie is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients.
Collaborations
Some of his notable coworkers include Xiaohua Chen and Jia Li, who contribute to the collaborative efforts in research and development within their institution.
Conclusion
Huijun Nie's innovative work in the field of pharmaceuticals highlights the importance of research in developing effective treatments for cancer. His contributions are paving the way for future advancements in medical science.